The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 27, 2015

Filed:

Jan. 31, 2013
Applicants:

Oregon Health & Science University, Portland, OR (US);

Vanderbilt University, Nashville, TN (US);

Inventors:

Andras Gruber, Portland, OR (US);

Erik I. Tucker, Portland, OR (US);

David Gailani, Franklin, TN (US);

Assignees:

Oregon Health & Science University, Portland, OR (US);

Vanderbilt University, Nashville, TN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/04 (2006.01); C07K 16/36 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/36 (2013.01); A61K 2039/505 (2013.01); C07K 2316/96 (2013.01);
Abstract

Disclosed herein are monoclonal antibodies specific for factor XI (fXI) that prevent activation of fXI by factor XIIa (fXIIa). The monoclonal antibodies are universal fXI antibodies, capable of binding all mammalian species tested. The anti-fXI monoclonal antibodies prolong clotting time in mammalian plasmas. Moreover, administration of the fXI monoclonal antibodies disclosed herein results in inhibition of thrombosis without altering hemostasis in animal models of thrombosis. Thus, provided herein are monoclonal antibodies specific for fXI that block activation of fXI by fXIIa, compositions and immunoconjugates comprising such antibodies and their methods of use.


Find Patent Forward Citations

Loading…